Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-17T16:47:27.797Z Has data issue: false hasContentIssue false

Lithium augmentation in venlafaxine non-responders: an open study

Published online by Cambridge University Press:  16 April 2020

G. Bertschy*
Affiliation:
Clinic of Adult Psychiatry, Department of Psychiatry, Geneva University, 2, ch. du Petit Bel-Air, Chene-Bourg, 1225Geneva, Switzerland
E. Ragama-Pardos
Affiliation:
Clinic of Adult Psychiatry, Department of Psychiatry, Geneva University, 2, ch. du Petit Bel-Air, Chene-Bourg, 1225Geneva, Switzerland
A. Aït-Ameur
Affiliation:
Clinic of Adult Psychiatry, Department of Psychiatry, Geneva University, 2, ch. du Petit Bel-Air, Chene-Bourg, 1225Geneva, Switzerland
S. Favre
Affiliation:
Clinic of Adult Psychiatry, Department of Psychiatry, Geneva University, 2, ch. du Petit Bel-Air, Chene-Bourg, 1225Geneva, Switzerland
L. Roth
Affiliation:
Clinic of Adult Psychiatry, Department of Psychiatry, Geneva University, 2, ch. du Petit Bel-Air, Chene-Bourg, 1225Geneva, Switzerland
*
*Corresponding author. E-mail address: gilles.bertschy@hcuge.ch (G. Bertschy).
Get access

Abstract

Thirteen major depressive patients not responding to a 4-week venlafaxine 300 mg treatment were eligible for a 4-week open trial of lithium addition. Two patients had to stop lithium for a possible moderate serotonin syndrome and five patients became responders, including one dramatic response and two semi-rapid responses.

Information

Type
Short communication
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Submit a response

Comments

No Comments have been published for this article.